Clinical Trial Update: Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ezetimibe with extended-release niacin for atherosclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Extended-release Niacin (Niacin (extended-release))

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Atherosclerosis | Phase 4 | Status: TERMINATED